Strona główna

  • Banner

  • Reduced price
  • New
Elsevier's 2027 Intravenous Medications

Elsevier's 2027 Intravenous Medications

9780443433368
267,07 zł
227,01 zł Save 40,06 zł Tax included
Lowest price within 30 days before promotion: 227,01 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Product Details
Elsevier
104539
9780443433368
9780443433368

Data sheet

Rok wydania
2026
Numer wydania
43
Oprawa
miękka bindowana
Liczba stron
1344
Wymiary (mm)
152 x 229
Waga (g)
450
  • General Dilution Charts
    How to Use This Book
    Evolve Website Information
    Format and Content of Intravenous Medications
    Key to Abbreviations
    Important IV Therapy Facts
    Resources
    IV Drugs
    Alphabetical Drug Monographs
    Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
    Appendix B: FDA Pregnancy Categories
    Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
    Appendix D: Information for Patients Receiving Immunosuppressive Agents
    Appendix E: Recently Approved Drugs
    Index
Comments (0)
Viewed products

  • Frequently purchased together

    No products available